Clinical Trial: Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title:

Brief Summary: This study will evaluate the safety and efficacy of bimatoprost solution 0.03% once daily to the upper eyelid margins (where the eyelashes meet the skin) compared with vehicle in increasing overall eyelash prominence in self-identified African American/ethnic black subjects exhibiting hypotrichosis of the eyelashes (inadequate or not enough eyelashes).

Detailed Summary:
Sponsor: Allergan

Current Primary Outcome: Percentage of Treatment Responders in Overall Eyelash Prominence at Month 4 [ Time Frame: Month 4 ]

Percentage of treatment responders in overall eyelash prominence, defined as at least a 1-grade improvement from baseline at Month 4 in the Global Eyelash Assessment (GEA) Scale. The GEA is a 4-point scale in which eyelash prominence is assessed from 1 (minimal prominence) to 4 (very marked prominence).


Original Primary Outcome: Overall Eyelash Prominence [ Time Frame: Month 4 ]

Current Secondary Outcome:

Original Secondary Outcome: Patient Questionnaires [ Time Frame: Month 4 ]

Information By: Allergan

Dates:
Date Received: August 11, 2009
Date Started: November 2009
Date Completion:
Last Updated: November 30, 2011
Last Verified: November 2011